FilingSEC EDGAR8-K/A
Jasper Therapeutics files amendment to include financial statements for Kira Pharmaceuticals acquisition.
· SEC accepted
StageAcquisition completed
Filing content
The company filed an amended report to include previously omitted audited and unaudited financial statements and pro forma information regarding the acquisition of Kira Pharmaceuticals.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…